Why Windtree Therapeutics Stock Is Moving Today
Windtree Therapeutics Inc (NASDAQ: WINT) shares are trading higher by 32% at $2.63 in Friday's premarket session after Oppenheimer initiated coverage on the stock with an Outperform rating and an $8 price target.